CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 5,000 shares at $3.28 ($16,400)
- 4 Open-market buy Director bought 2,000 shares at $3.20 ($6,400)
- 4 Open-market buy Director bought 6,000 shares at $3.08 ($18,480)
- 4 Open-market buy Director bought 11,000 shares at $3.08 ($33,880)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $3.00 ($60,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Director nominations
- 4 Other acquisition COO & CFO acquired 743 shares (other)
- 4 Open-market buy Director bought 18,244 shares at $4.76 ($86,841)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $4.77 ($9,540)
Page 8 of 50 · 983 filings